Welcome to our dedicated page for Aspen Aerogels news (Ticker: ASPN), a resource for investors and traders seeking the latest updates and insights on Aspen Aerogels stock.
Aspen Aerogels, Inc. develops and manufactures aerogel-based insulation and thermal-management products for energy industrial and electrification markets. Company news commonly covers financial results, segment trends in Energy Industrial and Thermal Barrier, customer demand for EV thermal barriers, and project activity tied to energy infrastructure and subsea pipeline applications.
Recurring updates also address Aspen's Aerogel Technology Platform, products such as PyroThin, Cryogel and Pyrogel, manufacturing operations, commercial settlements, credit-facility amendments and other capital-position disclosures. Operational news includes facility status updates when production, insurance claims or business-continuity matters affect the company's manufacturing footprint.
Aspen Aerogels (NYSE: ASPN) began a staged restart of manufacturing at its East Providence, Rhode Island facility following an April 8 incident. The restart follows comprehensive mechanical, operational, and safety reviews with local, state, and federal agencies.
The company plans a deliberate, phased ramp-up, and expects restoring full capabilities will take time, emphasizing employee and community safety as its top priority.
Aspen Aerogels (NYSE: ASPN) reported Q1 2026 revenue of $37.9M versus $78.7M a year earlier and a net loss of $23.7M. The company received a $37.6M cash settlement from General Motors; quarter-end cash was $175.6M. An explosion at the East Providence plant damaged production space; a staged restart is expected beginning in May. Q2 2026 guidance: revenue $40M–$48M, net loss $14M–$20M, adjusted EBITDA $(4)M–$(10)M; FY 2026 capex $10M.
Aspen Aerogels (NYSE: ASPN) will release first-quarter 2026 financial results before the market opens on Thursday, May 7, 2026, and will host a conference call at 8:30 a.m. ET that same day.
Executives Don Young (President & CEO) and Grant Thoele (CFO) will discuss results. Dial-in numbers, Meeting ID 717749648, a live listen-only webcast and a replay available on Aspen's investor website for ~one year.
Aspen Aerogels (NYSE: ASPN) provided an update on its East Providence, Rhode Island manufacturing facility after an explosion on April 8, 2026 that damaged production space and halted operations.
Preliminary reports indicate the blast originated in a high-temperature oven. Eleven employees were transported for evaluation and released. The facility remained offline as of April 21, 2026. Aspen has initiated insurance claims and will provide a further update with its fiscal 2026 Q1 earnings in early May.
Aspen Aerogels (NYSE: ASPN) confirmed an incident occurred the evening of April 8, 2026 at its East Providence, Rhode Island manufacturing facility. The site is secure, the situation is under control, and all eleven employees transported for evaluation have been released.
The company said it is assessing impact, has opened a full investigation, and is cooperating with local authorities; further updates will be provided as warranted.
Aspen Aerogels (NYSE: ASPN) will participate in the 38th Annual Roth Conference on Monday, March 23, 2026, at the Ritz Carlton in Laguna Niguel, CA. Don Young, President & Chief Executive Officer, and Neal Baranosky, Senior Director, Head of Investor Relations & Corporate Strategy, will hold one‑on‑one investor meetings. Investors should contact their Roth representative to arrange meetings.
Aspen Aerogels (NYSE: ASPN) reported sharply lower revenue and large losses for Q4 and FY2025, citing reduced EV-related demand and charges tied to reassessed capacity.
Total FY2025 revenue was $271.1M vs. $452.7M prior year; FY net loss was $389.6M including a $291.2M impairment. Year-end cash was $158.6M and the company expects a $37.6M GM settlement in Q1 2026.
Aspen Aerogels (NYSE: ASPN) will release fourth quarter and fiscal year 2025 results before market open on February 25, 2026 and will host a conference call that day at 8:30 a.m. ET with CEO Don Young and CFO Grant Thoele.
The call will be available by phone (conference ID 539718) and as a listen-only webcast on Aspen's Investors website; a replay will remain online for about one year.
Aspen Aerogels (NYSE: ASPN) announced on Dec. 17, 2025 that it entered into an amendment to its Credit, Security and Guaranty Agreement with MidCap Financial.
The amendment updates the company's financial covenant framework to provide additional flexibility and includes other technical changes intended to enhance Aspen's financial position. Aspen's CFO said liquidity is trending ahead of expectations due to operational efficiencies, working capital improvements, and prudent capital spending. The amendment will be filed with the Securities and Exchange Commission.
Aspen Aerogels (NYSE: ASPN) reported Q3 2025 revenue of $73.0M and a net loss of $6.3M on Nov 6, 2025. Revenue fell from $117.3M in Q3 2024; adjusted EBITDA was $6.3M. The company updated full‑year 2025 guidance to $270–280M revenue and adjusted EBITDA of $7–15M, citing lower near‑term U.S. EV production.
Key items: PyroThin award from a major European OEM with production start targeted in 2027, $152.4M cash, $15M operating cash flow, and a $287.6M impairment charge reflected in outlook.